Cite
HARVARD Citation
Conte, B. et al. (n.d.). 326PEffectiveness of trastuzumab emtansine (TDM1) in patients with HER2-positive advanced breast cancer (ABC) progressing after taxane plus pertuzumab plus trastuzumab. Annals of oncology. p. . [Online].